A Silver Lining? Fewer Non–Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Nonpharmaceutical interventions (NPIs) have “flattened the curve” of the coronavirus disease 2019 pandemic; however the effect of these interventions on other respiratory viruses is unknown. We used aggregate level case count data for 8 respiratory viruses and compared the institutional and statewide case counts before and during the period that NPIs were active. We observed a 61% decrease (incidence rate ratio, 0.39; 95% confidence interval, .37–.41; P < .001) in non–severe acute respiratory syndrome coronavirus 2 respiratory viral infections when NPIs were implemented. This finding, if further verified, should guide future public health initiatives to mitigate viral epidemics.

Original languageEnglish (US)
Pages (from-to)1751-1755
Number of pages5
JournalJournal of Infectious Diseases
Volume224
Issue number10
DOIs
StatePublished - Nov 15 2021

Keywords

  • COVID-19
  • nonpharmaceutical interventions
  • respiratory virus
  • seasonal respiratory viruses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'A Silver Lining? Fewer Non–Severe Acute Respiratory Syndrome Coronavirus 2 Respiratory Viruses During the Coronavirus Disease 2019 Pandemic'. Together they form a unique fingerprint.

Cite this